Next Article in Journal
The Possible Role of Complete Loss of Myostatin in Limiting Excessive Proliferation of Muscle Cells (C2C12) via Activation of MicroRNAs
Previous Article in Journal
Placental CX3CL1 is Deregulated by Angiotensin II and Contributes to a Pro-Inflammatory Trophoblast-Monocyte Interaction
Article Menu
Issue 3 (February-1) cover image

Export Article

Open AccessReview

Cyclodextrin–Drug Inclusion Complexes: In Vivo and In Vitro Approaches

Chemistry Department, Amazonas Federal University, Av. Rodrigo Octavio, 6200, Manaus AM 69080-900, Brazil
Department of Pharmacy, Federal University of Rio Grande do Norte, Natal RN 59012-570, Brazil
Laboratory of Neuroscience and Pharmacological Assays (LANEF), Federal University of Sergipe, São Cristóvão SE 49100-000, Brazil
Military Institute of Engineering, Praça General Tiburcio, 80, Praia Vermelha, Rio de Janeiro RJ 22290-290, Brazil
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(3), 642;
Received: 20 November 2018 / Revised: 21 December 2018 / Accepted: 27 December 2018 / Published: 2 February 2019
(This article belongs to the Section Biochemistry)
PDF [1821 KB, uploaded 2 February 2019]
  |     |  


This review aims to provide a critical review of the biological performance of natural and synthetic substances complexed with cyclodextrins, highlighting: (i) inclusion complexes with cyclodextrins and their biological studies in vitro and in vivo; (ii) Evaluation and comparison of the bioactive efficacy of complexed and non-complexed substances; (iii) Chemical and biological performance tests of inclusion complexes, aimed at the development of new pharmaceutical products. Based on the evidence presented in the review, it is clear that cyclodextrins play a vital role in the development of inclusion complexes which promote improvements in the chemical and biological properties of the complexed active principles, as well as providing improved solubility and aqueous stability. Although the literature shows the importance of their ability to help produce innovative biotechnological substances, we still need more studies to develop and expand their therapeutic properties. It is, therefore, very important to gather together evidence of the effectiveness of inclusion complexes with cyclodextrins in order to facilitate a better understanding of research on this topic and encourage further studies. View Full-Text
Keywords: cyclodextrins; substances; inclusion complexes; pharmaceutical technology; biological assays; drug delivery cyclodextrins; substances; inclusion complexes; pharmaceutical technology; biological assays; drug delivery

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Carneiro, S.B.; Costa Duarte, F.Í.; Heimfarth, L.; Siqueira Quintans, J.S.; Quintans-Júnior, L.J.; Veiga Júnior, V.F.; Neves de Lima, Á.A. Cyclodextrin–Drug Inclusion Complexes: In Vivo and In Vitro Approaches. Int. J. Mol. Sci. 2019, 20, 642.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top